PB1946: ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENA (AAMT), A SINGLE CENTER EXPERIENCE

PB1946: ACQUIRED AMEGAKARYOCYTIC THROMBOCYTOPENA (AAMT), A SINGLE CENTER EXPERIENCE

Bibliographic Details
Main Authors:	S. Mohamed, S. Kohla, K. Ahmed, A. Amer, K. Obeidat, D. Soliman, F. Ibrahim
Format:	Article
Language:	English
Published:	Wiley 2022-06-01
Series:	HemaSphere
Online Access:	http://journals.lww.com/10.1097/01.HS9.0000850624.34897.60

Similar Items

Acquired Amegakaryocytic Thrombocytopenia Progressingto Aplastic Anaemia
by: Syed Ather Hussain, et al.
Published: (2022-09-01)

Successful treatment of acquired amegakaryocytic thrombocytopenia with eltrombopag and immunosuppressant
by: Hong Tian, et al.
Published: (2022-08-01)

Hard to find and tricky to treat: A case series of acquired amegakaryocytic thrombocytopenia
by: Amina Anwar, et al.
Published: (2023-09-01)

PB2066: SYSTEMIC LUPUS ERYTHEMATOSUS-INDUCED AMEGAKARYOCYTIC THROMBOCYTOPENIA AND SUBSEQUENT APLASTIC ANEMIA
by: Gyuhee Seong, et al.
Published: (2023-08-01)

Thrombopoietin mutation in congenital amegakaryocytic thrombocytopenia treatable with romiplostim
by: Alessandro Pecci, et al.
Published: (2018-01-01)

Case Report: Successful Avatrombopag Treatment for Two Cases of Anti-PD-1 Antibody-Induced Acquired Amegakaryocytic Thrombocytopenia
by: Xiaofang Tu, et al.
Published: (2022-01-01)

Invasive thymoma with pure red cell aplasia and amegakaryocytic thrombocytopenia
by: Takuya Onuki, et al.
Published: (2016-12-01)

PB1940: ACQUIRED APLASTIC ANEMIA: THE CHALLENGE OF TREATMENT IN MEXICO. SINGLE HEMATOLOGY CENTER EXPERIENCE
by: M. L. Guajardo Leal, et al.
Published: (2022-06-01)

PB2046: CHANGINGS IN GENETIC DEFINITION AND MANAGEMENT OF ACQUIRED APLASTIC ANEMIA: A SINGLE CENTER EXPERIENCE
by: Marta Bortolotti, et al.
Published: (2023-08-01)

Genetic diversity in wild species and cultivars of strawberry for the <i>FanAAMT</i> gene controlling fruit flavor volatiles
by: A. S. Lyzhin, et al.
Published: (2021-07-01)

Successful avatrombopag combined with cyclosporine treatment for carboplatin/pegylated liposomal doxorubicin/bevacizumab-induced acquired amegakaryocytic thrombocytopenia in a patient with recurrent ovarian cancer: case report
by: Weikang Meng, et al.
Published: (2024-02-01)

PB2052: CLINICOPATHOLOGIC VARIABLES AFFECTING DISEASE OUTCOME IN PRIMARY MYELOFIBROSIS. A SINGLE CENTER EXPERIENCE.
by: S. Elkourashy, et al.
Published: (2022-06-01)

A novel missense mutation in the MECOM gene in a Chinese boy with radioulnar synostosis with amegakaryocytic thrombocytopenia
by: Duowen Huang, et al.
Published: (2024-01-01)

Anti-CD20 Antibody is Effective in the Patient with Refractory Amegakaryocytic Thrombocytopenia, 25 Months Follow up
by: Mehrzad Mirzania, et al.
Published: (2014-06-01)

Severe Clinical Course in a Patient with Congenital Amegakaryocytic Thrombocytopenia Due to a Missense Mutation of the c-MPL Gene
by: İkbal Ok Bozkaya, et al.
Published: (2015-05-01)

Outcomes and prognostic factors of infantile acquired hydrocephalus: a single-center experience
by: Faliang Zhou, et al.
Published: (2023-05-01)

PB2702: POLYPHARMACY IN HEMATOLOGY PRACTISE: A SINGLE CENTER EXPERIENCE
by: Kadir Karişmaz, et al.
Published: (2023-08-01)

PB2218: CHILDHOOD MYELPROLIFERATIVE NEOPLASMS; A SINGLE CENTER EXPERIENCE
by: Hasanein Ghali, et al.
Published: (2023-08-01)

PB2304: THROMBOTIC THROMBOCYTOPENIC PURPURA (TTP): A SINGLE-CENTER EXPERIENCE
by: F. Kammoun, et al.
Published: (2022-06-01)

PB2015: YOUNG ADULTS WITH MULTIPLE MYELOMA – A SINGLE CENTER EXPERIENCE
by: I. Dos Santos Marques, et al.
Published: (2022-06-01)

PB2051: PRIMARY MYELOFIBROSIS IN YOUNG PATIENTS ≤50 YEARS: CLINICOPATHOLOGICAL CHARACTERISTICS, GENETIC LANDSCAPE AND DISEASE OUTCOME. A SINGLE CENTER EXPERIENCE
by: S. Elkourashy, et al.
Published: (2022-06-01)

Six cases of autoimmune acquired coagulation factor VIII deficiency: Single center experience in Japan
by: Akiko Konishi, et al.
Published: (2020-11-01)

Evaluating the feasibility and exploring the efficacy of an emotion-based approach-avoidance modification training (eAAMT) in the context of perceived stress in an adult sample — protocol of a parallel randomized controlled pilot study
by: Marie Keinert, et al.
Published: (2023-09-01)

PB2345: MOGAMULIZUMAB IN MYCOSIS FUNGOIDES AND SÈZARY SYNDROME: AN ITALIAN SINGLE CENTER EXPERIENCE
by: Maria Pina Simula, et al.
Published: (2023-08-01)

PB2609: 14 YEARS OF EXPERIENCE WITH THROMBOPOIETIN RECEPTOR AGONISTS IN A SINGLE CENTER
by: Francesc Garcia-Pallarols, et al.
Published: (2023-08-01)

PB1939: CLINICAL AND GENETIC CHARACTERISTICS OF PATIENTS WITH GAUCHER DISEASE: A SINGLE CENTER EXPERIENCE
by: S. Elsayed, et al.
Published: (2022-06-01)

PB2022: ELTROMBOPAG IN MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA: A SINGLE-CENTER EXPERIENCE
by: Amaia Lopez Peña, et al.
Published: (2023-08-01)

PB2017: YOUNG PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA AND RENAL IMPAIRMENT: A TUNISIAN SINGLE-CENTER EXPERIENCE
by: F. Kallel, et al.
Published: (2022-06-01)

PB2257: OUTCOME AND PROGNOSTIC FACTORS OF PEDIATRIC PATIENTS WITH HODGKIN LYMPHOMA: A SINGLE-CENTER EXPERIENCE
by: Nesreen Ali, et al.
Published: (2023-08-01)

PB2092: PRIMARY BONE DIFFUSE LARGE B CELL LYMPHOMA: A SINGLE CENTER EXPERIENCE
by: G. Abichou, et al.
Published: (2022-06-01)

PB2238: ATYPICAL CHRONIC MYELOID LEUKEMIA. CLINICAL AND MOLECULAR FEATURES. A SINGLE CENTER EXPERIENCE.
by: Javier Alberto Rojas Martínez, et al.
Published: (2023-08-01)

PB2624: CLINICAL WHOLE EXOM SEQUENCING FOR CONGENITAL PLATELET DISORDERS: ONE SINGLE CENTER EXPERIENCE
by: Victor Portela Piñeiro, et al.
Published: (2023-08-01)

PB2336: TREATMENT PATTERN AND OUTCOME IN SYSTEMIC T AND NK CELL LYMPHOMA: AN ASIAN SINGLE CENTER EXPERIENCE
by: Meng-Ta Sung, et al.
Published: (2023-08-01)

PB1767: OUTCOME OF RELAPSED CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN THE SOUTH OF TUNISIA SINGLE CENTER EXPERIENCE
by: N. Siala, et al.
Published: (2022-06-01)

PB1946: NOTCH PATHWAY MUTATION CONTRIBUTES TO INFERIOR PROGNOSIS IN HBV-INFECTED CHRONIC LYMPHOCYTIC LEUKEMIA
by: Chunyu Shang, et al.
Published: (2023-08-01)

PB2323: ACQUIRED HEMOPHILIA: A CASE REPORT
by: N. Haddad, et al.
Published: (2022-06-01)

PB2534: SARS-COV-2 IMMUNIZATION AFTER VACCINES IN PATIENTS WITH HEMOGLOBINOPATHY: A SINGLE CENTER EXPERIENCE
by: Andrea Duminuco, et al.
Published: (2023-08-01)

PB2180: EPIDEMIOLOGICAL CHARACTERS OF ADULT EGYPTIAN STEM CELL TRANSPLANT PATIENTS: A SINGLE CENTER EXPERIENCE
by: M. Elbogdady, et al.
Published: (2022-06-01)

PB2260: FIVE-YEAR SINGLE-CENTER EXPERIENCE IN THE TREATMENT OF ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA WITH ABVD
by: Vojin Vukovic, et al.
Published: (2023-08-01)

PB2215: HYDROXYUREA-INDUCED CUTANEUS ADVERSE EVENTS IN PATIENTS WITH ESSENTIAL THROMBOCYTHEMIA: A SINGLE-CENTER EXPERIENCE
by: Amaia Lopez Peña, et al.
Published: (2023-08-01)